
Dalton Transactions p. 4437 - 4450 (2014)
Update date:2022-08-04
Topics:
Hohloch, Stephan
Schweinfurth, David
Sommer, Michael G.
Weisser, Fritz
Deibel, Naina
Ehret, Fabian
Sarkar, Biprajit
The compounds [Ru(bpy)2(L1)](ClO4) 2 (1(ClO4)2), [Ru(bpy)2(L 2)](ClO4)2 (2(ClO4)2), [Ru(bpy)2(L3)](ClO4)2 (3(ClO 4)2), [Ru(bpy)2(L4)](ClO 4)2 (4(ClO4)2), [Ru(bpy) 2(L5)](ClO4)2 (5(ClO 4)2), and [Ru(bpy)2(L6)](ClO 4)26(ClO4)2 (bpy = 2,2′-bipyridine, L1 = 1-(4-isopropyl-phenyl)-4-(2-pyridyl)-1,2, 3-triazole, L2 = 1-(4-butoxy-phenyl)-4-(2-pyridyl)-1,2,3-triazole, L3 = 1-(2-trifluoromethyl-phenyl)-4-(2-pyridyl)-1,2,3-triazole, L4 = 4,4′-bis-{1-(2,6-diisopropyl-phenyl)}-1,2,3-triazole, L5 = 4,4′-bis-{(1-phenyl)}-1,2,3-triazole, L6 = 4,4′-bis-{1-(2-trifluoromethyl-phenyl)}-1,2,3-triazole) were synthesized from [Ru(bpy)2(EtOH)2](ClO4)2 and the corresponding click -derived pyridyl-triazole or bis-triazole ligands, and characterized by 1H-NMR spectroscopy, elemental analysis, mass spectrometry and X-ray crystallography. Structural analysis showed a distorted octahedral coordination environment about the Ru(ii) centers, and shorter Ru-N(triazole) bond distances compared to Ru-N(pyridine) distances in complexes of mixed-donor ligands. All the complexes were subjected to cyclic voltammetric studies, and the results were compared to the well-known [Ru(bpy)3]2+ compound. The oxidation and reduction potentials were found to be largely uninfluenced by ligand changes, with all the investigated complexes showing their oxidation and reduction steps at rather similar potentials. A combined UV-vis-NIR and EPR spectroelectrochemical investigation, together with DFT calculations, was used to determine the site of electron transfer in these complexes. These results provided insights into their electronic structures in the various investigated redox states, showed subtle differences in the spectroscopic signatures of these complexes despite their similar electrochemical properties, and provided clues to the unperturbed redox potentials in these complexes with respect to ligand substitutions. The reduced forms of the complexes display structured absorption bands in the NIR region. Additionally, we also present new synthetic routes for the ligands presented here using Cu-abnormal carbene catalysts.
Xi'an yuanfar international trade company
website:https://www.yuanfarchemical.com
Contact:86-029-88745613 ext 828
Address:Floor19th ,B Building, Oak Block,No.36 South Fenghui Road, Dev. Zone of High-Tech Ind.,Xi’an, China
Hangzhou Pharma & Chem Co.,Ltd.
Contact:+86-571-87040515
Address:No,139Qingchun Rd
Contact:+1 (647) 918 5848
Address:2343 BRIMLEY RD., Suite 250
Beijing Tianjia Chemical Science & Technology Co.,Ltd
Contact:86-0550-2392698
Address:No.388, Shiliang Road (East),
Kaiping Genuine Biochemical Pharmaceutical Co.,Ltd.
Contact:+86-750-2881198
Address:No.1, Xinke Road, Shatang Town, Kaiping, Guangdong Province, P.R.China
Doi:10.1039/C6DT04811K
(2017)Doi:10.1016/j.tetasy.2008.03.016
(2008)Doi:10.1021/ja00279a059
(1986)Doi:10.1016/j.tet.2008.03.038
(2008)Doi:10.1016/S0040-4039(00)95141-4
(1985)Doi:10.1016/S0040-4020(01)96713-4
(1985)